Affiliation:
1. MANİSA CELÂL BAYAR ÜNİVERSİTESİ
2. CELÂL BAYAR ÜNİVERSİTESİ, TIP FAKÜLTESİ
Abstract
Hodgkin lymphoma is lymphoid neoplasm in which the malignant cells admixed with a
heterogeneous population of non-neoplastic inflammatory cells. A combination of
Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine (ABVD) is the most commonly
used chemotherapy regime for Hodgkin lymphoma. In this case report, we present a
patient with Hodgkin lymphoma who developed bilateral auricular hematoma after a
first time administrition of ABVD treatment. A 27-year-old female patient was presented
to the hematology outpatient clinic with a swelling in the neck for two weeks. An
excisional biopsy performed from the left axillary region. The pathology report
demonstrated classical Hodgkin lymphoma was noticed to be consistent with mixed
cellular type. First dose ABVD protocol was administered to the patient. One week after
chemotherapy, swelling and discoloration were observed in the patient's bilateral
auricles without a history of trauma. The patient was consulted to the Department of
Otorhinolarngology-Head and Neck Surgery. Bilateral drainage of auricular hematoma
was performed immediately. Intravenous ciprofloxacin was also administered. The
auricular hematoma did not reoccur after the subsequent chemotherapy treatments.